A new publication from our multinational BEST-CLI collaboration, now in the Journal of Vascular Surgery, underscores a simple but powerful truth: patients with chronic limb-threatening ischemia (CLTI) do better when they are treated by a team.
A new study published in the International Wound Journal highlights a striking parallel: the three-year recurrence rates for diabetic foot ulcers (DFU) and reintervention for chronic limb-threatening ischemia (CLTI) are comparable to—or exceed—those of advanced-stage cancers, including colorectal, breast, prostate, and even lung cancer.
Chongqing, Los Angeles — A landmark global study published today in Research (DOI: 10.34133/research.0702) projects a 220% increase in peripheral artery disease (PAD) cases worldwide by 2050, with prevalence expected to rise from 113 million in 2021 to more than 360 million.